Last reviewed · How we verify
bephenium
bephenium is a bephenium drug. It is currently in unknown development.
Bephenium is thought to work by modulating the activity of certain enzymes or receptors in the body.
Bephenium is a small molecule used as an anthelmintic agent. It is indicated for the treatment of hookworm infections and ascariasis.
At a glance
| Generic name | bephenium |
|---|---|
| Drug class | bephenium |
| Therapeutic area | Other |
| Phase | unknown |
Mechanism of action
Imagine bephenium as a key that fits into a specific lock in the body, allowing it to turn on or off certain cellular processes. This can help to regulate various bodily functions, but the exact details of how it works are not well understood. More research is needed to fully understand bephenium's mechanism of action.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- bephenium CI brief — competitive landscape report
- bephenium updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about bephenium
What is bephenium?
How does bephenium work?
What drug class is bephenium in?
What development phase is bephenium in?
Related
- Drug class: All bephenium drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing